Published - Sat, 08 Oct 2022

Cardiogenic Shock: Causes, Signs & Treatment

Cardiogenic Shock: Causes, Signs & Treatment

Cardiogenic shock occurs when the heart is unable to maintain perfusion adequate for the metabolic demands of the tissues.


CAUSES

The cause of cardiogenic shock is usually acute MI, especially after extensive infarction of the anterior ventricular wall. In patients with smaller infarcts, complications of acute MI, such as papillary muscle rupture, septal rupture, or right ventricular infarct, can cause cardiogenic shock. Myocarditis, cardiomyopathy, and valvular stenosis are further reasons.


CLINICAL FEATURES

1. History: Most patients are unable to give a history, but efforts should be made to gather information from fire-rescue personnel, family members, or other witnesses.

2. Physical examination findings include hypotension and tachycardia. Normal symptoms include diaphoresis, chilly extremities, and inadequate capillary refill. Breath sounds may be clear initially, or rales from acute pulmonary edema may be present. An S3 gallop or a murmur from a ruptured papillary muscle, acute mitral regurgitation, or septal rupture may be heard.


DIFFERENTIAL DIAGNOSES include other causes of shock, cardiac tamponade, primary CHF, adult respiratory distress syndrome, asthma, and pulmonary embolism. A cardiac etiology is suggested by a patient in shock with risk factors for ischemic heart disease and signs of acute CHF.


EVALUATION

1. Electrocardiography: ST-segment elevation may be observed. Right-sided leads may show a right ventricular infarct pattern, which mandates therapy that differs from therapy for other causes of cardiogenic shock.

2. Radiography: A chest radiograph may appear normal initially or show signs of acute CHF.

3. Bedside echocardiography is useful for demonstrating poor left ventricular function, assessing valvular integrity, and ruling out other causes of shock, such as cardiac tamponade.

4. Laboratory studies: Blood studies are not of use in making the initial diagnosis but must be included in the overall evaluation. Cardiac enzyme studies, a CBC and serum electrolyte panel, BUN and creatinine levels, and coagulation studies should be ordered. The level of serum B-type natriuretic peptide is an indicator of CHF and is a prognostic indicator of survival.


THERAPY

1. Emergent therapy is aimed at hemodynamically stabilizing the patient with oxygen, airway control, and intravenous access. An effort should be made to maximize left ventricular function.

2. Volume expansion: If there is no sign of volume overload or pulmonary edema, volume expansion with 100-mL boluses of normal saline every 3 minutes should be tried until either adequate perfusion is restored or pulmonary congestion occurs. Right ventricular infarct patients require markedly higher filling pressures to maintain appropriate cardiac output.

3. Inotropic support

a) Patients with mild hypotension (i.e., a systolic blood pressure of 80 to 90 mm Hg) and pulmonary congestion are best treated with dobutamine (2.5 µg/kg/min, titrating upward by 2 to 3 µg/kg/min at 10-minute intervals). Dobutamine supports inotropy while very slightly raising the myocardial oxygen demand.

b) Patients with severe hypotension (i.e., a systolic blood pressure less than 75 to 80 mm Hg) should be treated with dopamine.

The effects of this medication depend on the dose. At doses of 2.5 to 10 µg/kg/min, it has positive inotropic and chronotropic effects. At dosages greater than 5.0 µg/kg/min, α-adrenergic stimulation gradually increases, causing peripheral vasoconstriction. At doses greater than 20µg/kg/min, dopamine increases ventricular irritability without additional benefit. Not all patients have the characteristic dose-related effects of dopamine.

A combination of dopamine and dobutamine is an effective therapeutic strategy for cardiogenic shock, minimizing the unwanted side effects of dopamine at high doses and providing inotropic support.

c) If additional support for blood pressure is needed, norepinephrine, which has much stronger α-adrenergic effects, can be tried. The initial dose ranges from 0.5 to 1µg/min.

d) Mechanical support (e.g., aortic counterpulsation) may be an option while arranging for more definitive management strategies.

4. Reperfusion therapy: Patients with acute MI and cardiogenic shock can only be treated effectively by reperfusion of the ischemic myocardium. The recommended modality is emergent PTCA.


DISPOSITION

Facilities without angiographic support should consider transferring the patient to a facility with a cardiac catheterization laboratory and cardiac surgery services.

Created by

Rigomo Team

Rigomo is a leading online education platform that offers a wide range of courses to help individuals enhance their skills and achieve their career goals. With our user-friendly interface and expert instructors, we strive to provide high-quality education to everyone, anytime and anywhere. Join us today and take the first step towards a brighter future.

Rigomo is an e-learning platform that was founded in 2019 by a team of dedicated professionals with a passion for revolutionizing the way people learn. The platform offers a range of online courses that cover various industries, including business, technology, healthcare, and more.

Rigomo's courses are designed to be interactive and engaging, with a focus on practical skills that learners can apply in their careers. The platform uses a combination of video lectures, quizzes, and hands-on projects to help learners master the subject matter.

Rigomo is committed to providing affordable and accessible education to people around the world. The platform offers a range of pricing options, including monthly and annual subscriptions, as well as pay-as-you-go options for individual courses.

Since its launch, Rigomo has received numerous accolades for its innovative approach to e-learning. The platform has helped thousands of learners across the globe acquire new skills and advance their careers.

As Rigomo continues to grow, the team remains committed to providing high-quality education that is accessible to all. The platform is constantly updating its courses and features to ensure that learners have access to the latest tools and technologies.

View profile

Comments (0)

Search
Popular categories
Latest blogs
Transforming Emergency Care: The Story Behind Rigomo's Revolutionary PPMMP Course
Transforming Emergency Care: The Story Behind Rigomo's Revolutionary PPMMP Course
In the bustling corridors of a major hospital in Mumbai, Dr. Ayesha Khan felt the pulse of emergency medicine beating at a frantic pace. As a seasoned emergency room physician, she had seen it all — from the heartbreaking to the miraculous. Yet, despite her years of experience, Dr. Khan often felt that something was missing — a gap between the theoretical knowledge she had acquired and the real-world application of managing complex patient scenarios. It was during one critical incident, a complicated case of a diabetic emergency with multiple complications, that the idea for a comprehensive training program began to take shape.Dr. Khan observed that while her team was highly educated, they often hesitated, unsure of the best course of action when standard procedures didn’t align perfectly with the complexities presented by real-life cases. This observation was the seed that grew into the Practical Patient Management Program (PPMMP), developed in collaboration with Rigomo, a pioneer in healthcare education.The Genesis of PPMMPThe journey began with a simple question: How could healthcare professionals bridge the gap between theoretical learning and practical execution? The answer lay in creating a dynamic, interactive, and comprehensive training environment that mirrored real-life medical emergencies more closely than traditional classrooms or online courses ever could.Dr. Khan approached Rigomo with her vision, and together, they crafted a curriculum that was deeply rooted in the realities of medical practice. They decided to focus on a multi-faceted approach, incorporating simulations of emergency scenarios, step-by-step analytical techniques, and patient management strategies under pressure.What Sets PPMMP Apart?From the outset, the PPMMP was designed to be different. It wasn’t just about learning what to do; it was about understanding why, how, and when to do it. The course covers a wide range of emergencies — from metabolic crises like diabetes to respiratory emergencies and anaphylaxis. Each module is built around the latest research and clinical guidelines, ensuring that participants receive the most up-to-date information possible.However, the real magic of the PPMMP lies in its delivery. Recognizing the linguistic diversity of India, the entire course is offered in Hindi, making it accessible to a broader range of healthcare professionals. This decision has democratized access to advanced medical training, particularly benefiting those in rural or underserved areas.A Real-World ImpactOne of the most compelling testimonials comes from Dr. Manav Arora, a young doctor who enrolled in the PPMMP shortly after its launch. During an overnight shift, Dr. Arora faced a severe case of pulmonary embolism — a situation he had only read about in textbooks. Armed with knowledge and hands-on practice from the PPMMP, he was able to lead his team effectively, administer the right interventions, and save a life that night. Dr. Arora credits the PPMMP for his confidence and quick decision-making skills.Looking AheadToday, the PPMMP is not just a course but a movement. It’s about empowering doctors, nurses, and paramedics with the confidence to take bold, informed actions in critical situations. As healthcare continues to evolve, Rigomo is committed to updating the curriculum to include new findings, techniques, and technologies.The success story of the PPMMP is a testament to the power of innovative thinking in education and the profound impact it can have on healthcare delivery. It stands as a beacon for future endeavors in medical training, highlighting the crucial link between knowledge and action in saving lives.The Practical Patient Management Program has grown significantly since its inception, touching the lives of numerous healthcare professionals across India. The course’s success has encouraged other institutions to look towards similar models of integrated, practical training programs. To learn more about the PPMMP or to enroll in this transformative course, please visit PPMMP at Rigomo https://ppmp.rigomo.com. By joining this program, you not only gain access to advanced medical training but also become part of a community dedicated to excellence in healthcare services. The platform’s easy-to-navigate interface and comprehensive resources ensure that every participant can maximize their learning potential and truly make a difference in their professional environments.

Sun, 12 May 2024

Empowering Rural Healthcare: How Pogiko's AI is Bridging the Gap in Medical Services
Empowering Rural Healthcare: How Pogiko's AI is Bridging the Gap in Medical Services
Access to quality healthcare remains a significant challenge in rural regions, where the scarcity of medical resources and professionals exacerbates health disparities. Pogiko, an innovative AI-powered tool from Rigomo Technologies, is emerging as a transformative solution to these challenges. This article delves deeper into how Pogiko is enhancing healthcare delivery in underserved areas.Technological Innovation Meets Rural Medicine Pogiko utilizes advanced AI algorithms to perform functions like disease diagnosis, medical report analysis, and case management, traditionally reserved for specialists in well-equipped urban centers. By automating these complex tasks, Pogiko provides rural doctors with the capabilities of a virtual specialist team, enabling them to offer comprehensive medical care even in resource-limited settings.Immediate Benefits of AI in Rural HealthcareEnhanced Diagnostic Accuracy: Pogiko's AI quickly interprets symptoms and medical data, providing accurate diagnostics that are crucial in areas where specialist consultation is rare or delayed.Decision Support: It offers real-time decision support to healthcare providers, aiding them in treatment planning and management, thus minimizing the risks associated with delayed care.Education and Training: Through regular updates and learning tools, Pogiko keeps rural healthcare providers abreast of the latest medical advancements and treatment protocols, significantly improving their knowledge base without the need for frequent travel for training.Case Management and Remote Assistance With Pogiko, rural healthcare practitioners can manage multiple cases efficiently, with AI suggesting the most effective treatment plans based on the latest guidelines and patient data. Additionally, its ability to facilitate remote consultations helps bridge the distance between rural practitioners and specialists in urban centers, fostering a collaborative approach to patient care.Long-Term Impact and Scalability The scalability of AI tools like Pogiko promises a broader reach, potentially transforming healthcare delivery in remote areas globally. By providing high-quality medical advice and support, Pogiko helps reduce healthcare inequalities, ensuring that rural populations have better health outcomes and access to advanced care practices.Pogiko exemplifies how AI can play a pivotal role in not just supporting but significantly enhancing healthcare in rural areas. As technology advances, the potential for AI to serve as a cornerstone in rural healthcare systems becomes increasingly evident, offering a beacon of hope for regions still struggling with the basics of medical care.

Thu, 25 Apr 2024

Advancements in the Treatment of Pulmonary Embolism: What's New in 2024?
Advancements in the Treatment of Pulmonary Embolism: What's New in 2024?
Artificial Intelligence in DiagnosisAdvancements in Endovascular TherapiesPersonalized Treatment ApproachesNew Pharmacological TreatmentsMultidisciplinary Care TeamsThe landscape of pulmonary embolism treatment in 2024 is characterized by rapid advancements in technology, personalized medical approaches, and the development of safer, more effective therapies. These innovations not only improve the quality of care received by patients but also significantly increase survival rates and enhance the quality of life following a PE diagnosis. As research continues and technologies evolve, we can expect even more impressive strides in the treatment of this challenging condition.

Wed, 24 Apr 2024

All blogs